Skip to main content
Hit enter to search or ESC to close
Close Search
Hepion PharmaceuticalsHepion Pharmaceuticals
Menu
  • About
    • Company Overview
    • Executive Team
    • Board of Directors
    • Partnering
  • Hepatocellular Carcinoma
  • Portfolio
  • Newsroom
  • Investors
    • Investor Overview
    • Press Releases
    • Presentations
    • Company Information
    • Stock Information
    • SEC Filings
    • Corporate Governance
  • Contact
    • Contact Us
    • Careers
  • linkedin
Hepion Pharmaceuticals

Hepatitis Quest Moves From C to B Under Ex-Gilead Leaders [via Bloomberg Business]

http://www.bloomberg.com/news/articles/2015-02-04/hepatitis-quest-moves-from-c-to-b-under-former-gilead-executives

Hepion Obtains HBV Candidate, Investment from Chimerix

http://www.biocentury.com/dailynews/company/2014-12-18/contravir-obtains-hbv-candidate-investment-from-chimerix
  • Previous
  • 1
  • 2
  • 3
About
Leadership
Hepatocellular Carcinoma
Portfolio
Newsroom
Contact
Subscribe for Updates

© 2026 Hepion Pharmaceuticals | Disclaimer & Terms of Use

Close Menu
  • About
    • Company Overview
    • Executive Team
    • Board of Directors
    • Partnering
  • Hepatocellular Carcinoma
  • Portfolio
  • Newsroom
  • Investors
    • Investor Overview
    • Press Releases
    • Presentations
    • Company Information
    • Stock Information
    • SEC Filings
    • Corporate Governance
  • Contact
    • Contact Us
    • Careers
  • linkedin